Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 12/20 | 0.64 |
| ▸ | PRSS1 | P07477 | 8/20 | 0.58 |
| ▸ | PRSS2 | P07478 | 8/20 | 0.58 |
| ▸ | PRSS3 | P35030 | 8/20 | 0.58 |
| ▸ | PLG | P00747 | 7/20 | 0.58 |
| ▸ | PLAU | P00749 | 1/20 | 0.58 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29679197 | 0.93 | PLG (0.68) | FOLH1PRSS1PRSS2PRSS3PLG | |
| SCHEMBL29679138 | 0.92 | FOLH1 (0.60) | FOLH1PRSS1PRSS2PRSS3PLG | |
| SCHEMBL29679159 | 0.92 | FOLH1 (0.62) | FOLH1PRSS1PRSS2PRSS3PLG | |
| SCHEMBL25963776 | 0.92 | FOLH1 (0.60) | FOLH1PRSS1PRSS2PRSS3PLG | |
| SCHEMBL23553003 | 0.91 | FOLH1 (0.76) | FOLH1PRSS1PRSS2PRSS3PLG | |
| SCHEMBL28659047 | 0.91 | FOLH1 (0.76) | FOLH1PRSS1PRSS2PRSS3PLG | |
| SCHEMBL29679057 | 0.91 | FOLH1 (0.76) | FOLH1PRSS1PRSS2PRSS3PLG | |
| SCHEMBL26090338 | 0.91 | FOLH1 (0.76) | FOLH1PRSS1PRSS2PRSS3PLG | |
| SCHEMBL29679477 | 0.91 | FOLH1 (0.76) | FOLH1PRSS1PRSS2PRSS3PLG | |
| SCHEMBL29679031 | 0.90 | PLG (0.60) | FOLH1PRSS1PRSS2PRSS3PLG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4003959-A1 | TARGETED RADIOPHARMACEUTICALS FOR THE DIAGNOSIS AND TREATMENT OF PROSTATE CANCER | Bayer AS (NO) | 2022-06-01 | — | — | EP | disclosed |